For all adverse event suspicion or a security issue concerning our products, please contact Finland’s affiliate:
By phone : +358 40 140 8856
Email: info@stragen.fi
Or our global pharmacovigilance department
By phone: +33 (0)4 78 42 95 26
By email: pharmacovigilance@stragen.fr
Please provide all details, as much as possible, on the adverse event, namely, informations of the patient, name of the medication, the dosage, route of administration and complete description of the event.
Reportings are essential to ensure a continuous monitoring and in improving the safety of medications. Please feel free to contact Stragen Finland or our pharmacovigilance team if you have any concerns or questions.
A niche generic drug is a generic version of a medication that serves specific and restricted needs of certain patient groups or particular medical conditions. Unlike traditional generic drugs, which are more affordable alternatives to popular brand-name medications, niche generic drugs are typically used to treat rare diseases, specific disorders, or limited populations. They may be developed to address unmet medical needs, specific formulation requirements, or unique safety and efficacy characteristics. Niche generic drugs often provide a more affordable therapeutic option for patients in areas where treatment choices are limited or brand-name drugs are excessively expensive.
A generic drug is an equivalent and more affordable version of an already approved and marketed brand-name medication. It contains the same active ingredients, the same dosage, and the same pharmaceutical form, but it is manufactured by a different company after the expiration of the original drug’s patent. Generic drugs are subject to strict standards of quality, safety, and efficacy, and they provide an affordable alternative to patients while maintaining the same therapeutic effectiveness as the brand-name medication.